<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388957</url>
  </required_header>
  <id_info>
    <org_study_id>UDDS-Pedo-02-2017</org_study_id>
    <nct_id>NCT03388957</nct_id>
  </id_info>
  <brief_title>Oral Propranolol for Reducing Pediatric Dental Patients Anxiety</brief_title>
  <official_title>Evaluating of Oral Propranolol Effect on Managing Anxiety of Dental Extractions in Children: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Damascus University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Damascus University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluating anxiety, heart rate and behavior during dental extractions after oral dose of&#xD;
      either Propranolol, Midazolam or a combination of both in uncooperative pediatric patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of 0.5 mg/kg of Propranolol or a combination of Propranolol and Midazolam for the first&#xD;
      time to manage uncooperative pediatric dental patients anxiety, comparing with Midazolam by&#xD;
      evaluating anxiety, heart rate and behavior during administration of local anesthesia and&#xD;
      extraction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 30, 2018</start_date>
  <completion_date type="Actual">February 15, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Three groups, with 20 children in each group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Anxiety-1 levels</measure>
    <time_frame>(1) five minutes before medication, (2) 30 minutes post-extraction</time_frame>
    <description>Anxiety-1 levels will be evaluated using self-reported faces anxiety scale (also called 'modified child dental anxiety scale). Scale name: Modified Child Dental Anxiety Scale (MCDAS):&#xD;
Relaxed/Not worried. (Better outcome)&#xD;
Very slightly worried.&#xD;
Fairly worried.&#xD;
Worried a lot.&#xD;
Very worried. (Worse outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Anxiety-2 levels</measure>
    <time_frame>(1) 45 minutes after medication, while applying local anesthesia, (2) after 10 minutes of applying the anesthesia and during tooth extraction.</time_frame>
    <description>Anxiety-2 levels will be measured using Observational Venham Anxiety Scale&#xD;
Major Issues: 1) Will be measured in 2 phases:&#xD;
45 minutes after medication, while applying local anesthesia.&#xD;
While extracting the tooth. &quot;Venham Anxiety Scale&quot;: 0. Relaxed. (Better outcome)&#xD;
Uneasy.&#xD;
Tense.&#xD;
Reluctant.&#xD;
Interference.&#xD;
Out of contact. (Worse outcome)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in heart rate</measure>
    <time_frame>(1) 5 minutes before medication, (2) 45 minutes after medication, while applying local anesthesia, (3) after 10 minutes of applying the anesthesia and during tooth extraction, (4) 30 minutes following extraction</time_frame>
    <description>using Finger Pulse Oximeter</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Behavior</measure>
    <time_frame>(1) 45 minutes after medication, while applying local anesthesia, (2) after 10 minutes of applying the anesthesia and during tooth extraction</time_frame>
    <description>using Observational Frankl Scale &quot;Frankl Scale&quot;:&#xD;
Definitely negative. (Worse outcome)&#xD;
Negative.&#xD;
Positive.&#xD;
Definitely positive. (Better outcome)</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Extrusion of Tooth</condition>
  <arm_group>
    <arm_group_label>Propranolol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given Propranolol 0.5 mg/Kg orally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given Midazolam 0.5 mg/Kg orally.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propranolol and Midazolam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will be given Propranolol and Midazolam with a dose of 0.5 mg/Kg orally for each drug.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propranolol</intervention_name>
    <description>This drug will be given before the extraction procedure</description>
    <arm_group_label>Propranolol</arm_group_label>
    <arm_group_label>Propranolol and Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>This drug will be given before the extraction procedure</description>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_label>Propranolol and Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  High to extreme fear of tooth or molar anesthesia and removal (Frankl: Definitely&#xD;
             negative).&#xD;
&#xD;
          -  Scoring more than 19 points on MCDAS(f).&#xD;
&#xD;
          -  Healthy pediatric patients (ASA I) aging 8-10 years.&#xD;
&#xD;
          -  Indication for primary tooth or molar extraction.&#xD;
&#xD;
          -  Fasting if indicated (severe gag reflex).&#xD;
&#xD;
          -  Airway assessment (Mallampati and tonsillar hypertrophy).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Asthma or any other obstructive pulmonary disease.&#xD;
&#xD;
          -  Cardiac failure.&#xD;
&#xD;
          -  Cardiac arrhythmia.&#xD;
&#xD;
          -  Renal failure.&#xD;
&#xD;
          -  Diabetes.&#xD;
&#xD;
          -  Current use of another ß-adrenoreceptor antagonist.&#xD;
&#xD;
          -  Current use of anxiolytic or antidepressant medication.&#xD;
&#xD;
          -  Currently in psychotherapy for dental anxiety.&#xD;
&#xD;
          -  Systolic blood pressure &lt;100 mmHg.&#xD;
&#xD;
          -  Diastolic blood pressure &lt;60 mmHg.&#xD;
&#xD;
          -  Active Upper respiratory infection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Abu Bakr, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>MSc student in Pedodontics, University of Damascus Dental School, Damascus, Syria</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohamed Altinawi, DDS MSc PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Professor of Pedodontics, University of Damascus Dental School, Damascus, SYRIA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youssef Latifeh, MD MSc Phd</last_name>
    <role>Study Director</role>
    <affiliation>Professor and Head of the Psychiatry Department, Damascus Univesrity, Damascus, Syria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Peadodontics, University of Damascus Dental School</name>
      <address>
        <city>Damascus</city>
        <zip>DM20AM18</zip>
        <country>Syrian Arab Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Syrian Arab Republic</country>
  </location_countries>
  <reference>
    <citation>Coté CJ, Wilson S; AMERICAN ACADEMY OF PEDIATRICS; AMERICAN ACADEMY OF PEDIATRIC DENTISTRY. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016. Pediatrics. 2016 Jul;138(1). pii: e20161212. doi: 10.1542/peds.2016-1212.</citation>
    <PMID>27354454</PMID>
  </reference>
  <reference>
    <citation>Gazal G, Fareed WM, Zafar MS, Al-Samadani KH. Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review. Saudi Pharm J. 2016 Jul;24(4):379-85. doi: 10.1016/j.jsps.2014.04.004. Epub 2014 Apr 26. Review.</citation>
    <PMID>27330369</PMID>
  </reference>
  <reference>
    <citation>Heaton LJ, McNeil DW, Milgrom P. Propranolol and D-cycloserine as adjunctive medications in reducing dental fear in sedation practice. SAAD Dig. 2010 Jan;26:27-35. Review.</citation>
    <PMID>20151608</PMID>
  </reference>
  <reference>
    <citation>LeCompte MT, Rae L, Kahn SA. A survey of the use of propranolol in burn centers: Who, what, when, why. Burns. 2017 Feb;43(1):121-126. doi: 10.1016/j.burns.2016.07.007. Epub 2016 Aug 27.</citation>
    <PMID>27575676</PMID>
  </reference>
  <reference>
    <citation>Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. J Psychopharmacol. 2016 Feb;30(2):128-39. doi: 10.1177/0269881115612236. Epub 2015 Oct 20. Review.</citation>
    <PMID>26487439</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 18, 2017</study_first_submitted>
  <study_first_submitted_qc>December 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2018</study_first_posted>
  <last_update_submitted>March 20, 2021</last_update_submitted>
  <last_update_submitted_qc>March 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propranolol</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

